Stocks to Buy

Whether you are a novice who just opened your first 401k or you are a seasoned investor, you have to spend countless hours researching stocks to buy. Who has that kind of time? We do. Powered by a diverse group of perspectives formed from dozens of analysts, advisors and strategists, our stories digest the day’s biggest headlines to uncover which stocks you should buy.

Add a Cathie Wood-Approved Software Startup to Your Portfolio With UiPath

By David Moadel, InvestorPlace Contributor
You can give PATH stock a try because Cathie Wood's fund added it or simply because you don't want to resist the automation revolution.

3 Cannabis Beverage Stocks to Buy to Ride the Weed Wave

By Faizan Farooque, InvestorPlace Contributor
Cannabis beverage stocks will continue to do well for the foreseeable future, considering we are motoring along to full U.S. legalization.

Etsy Stock Has a Realistic Chance of Approaching All-Time Highs Here

By Bret Kenwell, InvestorPlace Contributor
Etsy stock was hammered with the rest of the growth stocks, but is now making a comeback. How far can it run and can it get back to $250?

The Success of Lucid Air Will Make LCID Investors Into ‘Lucidnaires’

By Luke Lango and the InvestorPlace Research Staff
LCID stock flew from $20 to $27 in a matter of weeks after the previously mentioned EPA rating, and we expect Production Preview Week 1 to have a similar impact on share prices. And guess what? At those levels, the stock still wouldn't be overvalued.

4 Top Stock Trades for Tuesday: ACB, F, RIDE, NKE

By Bret Kenwell, InvestorPlace Contributor
Aurora Cannabis, Ford, Lordstown Motors and Nike were our top stock trades for Tuesday. Now, let's get a look at the charts.

Novavax: Big Market Potential, Meaningful Stock Upside

By Faisal Humayun, InvestorPlace Contributor
Even after a 5,690% gain, NVAX stock looks positioned for further upside with the firm's focus on bringing vaccines to low-income countries.

Novavax Has Growth Potential Both Now and After the Pandemic

By Louis Navellier and the InvestorPlace Research Staff
Novavax has a Covid-19 vaccine already in production. With a world that still needs billions of doses, NVAX stock is positioned for growth.

Greenidge Generation, Post-Merger, Looks Like a Bargain

By Mark R. Hake, CFA
Greenidge Generation, post the Support.com reverse merger, looks like a bargain. GREE stock is likely to do extremely well from here if the company's merger projections come true.

Don’t Be Fooled by ChargePoint Stock’s Failure to Charge Into October

By Will Ashworth, InvestorPlace Contributor
CHPT stock has struggled recently but remains an excellent speculative buy in the low $20s based on the company's outsized growth prospects.

It’s Time to Ignore the Short-Term Pain in Pinterest Stock

By Louis Navellier and the InvestorPlace Research Staff
Social media image sharing network Pinterest has seen U.S. user numbers fall as Americans emerge from lockdown, causing pain for PINS stock.

Nvidia Stock Heats Up Again Amid Renewed Optimism in Semiconductor Space

By Louis Navellier and the InvestorPlace Research Staff
NVDA stock popped after rosy reports about semiconductor industry growth in 2021, including growth in key Nvidia segments.

7 Chinese Stocks That Are Looking Really Cheap After Regulatory Curbs

By Chris MacDonald, InvestorPlace Contributor
Here's why investors looking for top Chinese stocks to buy certainly have their fair share of excellent options in this market right now.

Vaxart Traders Should Not Dismiss the Vaccine Maker’s Momentum

By Louis Navellier and the InvestorPlace Research Staff
The recently range-bound price action of VXRT stock doesn't reflect the progress that Vaxart is making against Covid-19.

8 Robinhood Stocks That Are Better Than Dogecoin

By Bret Kenwell, InvestorPlace Contributor
Dogecoin may have captivated excited investors, but there are plenty of exciting Robinhood stocks that offer a better buying opportunity.

7 Best Stocks to Buy Now to Protect Against a Potential Pullback

By Tezcan Gecgil, InvestorPlace Contributor
These seven stocks to buy look primed to increase revenue and earnings despite a potential pullback.

The Potential Nuclear Equipment Deal Is Another Plus for General Electric

By Louis Navellier and the InvestorPlace Research Staff
The $100 mark seems to be a sticking point for slow-moving GE stock. However, it may be best to be patient. General Electric remains focused.

Senseonics Stock Will Grow With Increased Product Awareness

By Louis Navellier and the InvestorPlace Research Staff
It has been a long road to commercializing the Eversense platform, but SENS stock holders should be glad to know that progress is being made.

Nio’s Year-to-Date Stat Is Not a Reason to Run

By Nicolas Chahine, InvestorPlace Contributor
Nio stock has rewarded its biggest fans with a 2000% win so far. It now offers short-term opportunities for traders and investors alike.

6 Bubble Stocks That Are Still Worth Taking a Chance On

By Alex Sirois, InvestorPlace Contributor
The term "bubble stocks" might make you think of losses, but these picks are actually strong contenders for survival.
Load More Articles